Meeting
2017 ASCO Annual Meeting
Targeted therapy for HER2 driven colorectal cancer.
Authors
Jeffrey S. Ross
Albany Medical College, Albany, NY
Jeffrey S. Ross , Siraj Mahamed Ali , Julia Andrea Elvin , Alexa Betzig Schrock , James Suh , Jo-Anne Vergilio , Shakti Ramkissoon , Eric Allan Severson , Sugganth Daniel , David Fabrizio , Garrett Michael Frampton , Vincent A. Miller , Philip J. Stephens , Laurie M. Gay
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Epidemiology/Outcomes
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3583)
DOI
10.1200/JCO.2017.35.15_suppl.3583
Abstract #
3583
Poster Bd #
206
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Gastrointestinal Cancers Symposium
A plasma-based analysis and genomic landscape of patients with high tumor mutational burden (TMB-H), microsatellite stable (MSS) colorectal cancer (CRC).
First Author: Anwaar Saeed
Poster
2018 Gastrointestinal Cancers Symposium
Comprehensive genomic profiling of appendiceal adenocarcinoma.
First Author: Kanwal Pratap Singh Raghav
Poster
2011 ASCO Annual Meeting
Comprehensive next-generation sequencing for clinically actionable mutations from formalin-fixed cancer tissues.
First Author: J. S. Ross
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Circulating tumor DNA–based genomic landscape of KRAS wild-type pancreatic adenocarcinoma.
First Author: Brendon Fusco